Literature DB >> 17876021

Changes in triglyceride levels and risk for coronary heart disease in young men.

Amir Tirosh1, Assaf Rudich, Tzippora Shochat, Dorit Tekes-Manova, Eran Israeli, Yaakov Henkin, Ilan Kochba, Iris Shai.   

Abstract

BACKGROUND: Current triglyceride levels might be only a weak predictor of risk for coronary heart disease (CHD).
OBJECTIVE: To assess the association between changes over time in fasting triglyceride levels and CHD risk in young adults.
DESIGN: Follow-up study over 5.5 years after 2 measurements of fasting triglycerides 5 years apart.
SETTING: The Staff Periodic Examination Center of the Israel Defense Forces, Zrifin, Israel. PATIENTS: 13,953 apparently healthy, untreated, young men (age 26 to 45 years) with triglyceride levels less than 3.39 mmol/L (<300 mg/dL). MEASUREMENTS: Two triglyceride measurements (at enrollment [time 1] and 5 years later [time 2]), lifestyle variables, and incident cases of angiography-proven CHD.
RESULTS: Within 5.5 years, 158 new cases of CHD were identified. The multivariate model was adjusted for age; family history; fasting glucose; high-density lipoprotein cholesterol; blood pressure; body mass index; and changes between time 1 and time 2 in body mass index, physical activity, smoking status, and habit of eating breakfast. Investigators categorized triglyceride levels according to low, intermediate, and high tertiles (as measured at time 1 and time 2 [expressed as tertile at time 1/tertile at time 2]). The risk for CHD in men with high-tertile triglyceride levels at time 1 changed depending on the tertile at time 2 (hazard ratios, 8.23 [95% CI, 2.50 to 27.13] for high/high, 6.84 [CI, 1.95 to 23.98] for high/intermediate, and 4.90 [CI, 1.01 to 24.55] for high/low, compared with the stable low/low group). The risk for CHD in men with low-tertile levels at time 1 also changed depending on the tertile at time 2 (hazard ratios, 3.81 [CI, 0.96 to 15.31] for low/intermediate and 6.76 [CI, 1.34 to 33.92] for low/high, compared with the stable low/low group). LIMITATIONS: Participants were healthy and had a low incidence rate of CHD. The study was observational.
CONCLUSIONS: Two triglyceride measurements obtained 5 years apart may assist in assessing CHD risk in young men. A decrease in initially elevated triglyceride levels is associated with a decrease in CHD risk compared with stable high triglyceride levels. However, this risk remains higher than in those with persistently low triglyceride levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876021     DOI: 10.7326/0003-4819-147-6-200709180-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  48 in total

Review 1.  Risk factors preceding type 2 diabetes and cardiomyopathy.

Authors:  Shamjeet Singh; Sanjiv Dhingra; Dan D Ramdath; Sudesh Vasdev; Vicki Gill; Pawan K Singal
Journal:  J Cardiovasc Transl Res       Date:  2010-07-01       Impact factor: 4.132

2.  Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study.

Authors:  Nicolas Amabile; Susan Cheng; Jean Marie Renard; Martin G Larson; Anahita Ghorbani; Elizabeth McCabe; Gabriel Griffin; Coralie Guerin; Jennifer E Ho; Stanley Y Shaw; Kenneth S Cohen; Ramachandran S Vasan; Alain Tedgui; Chantal M Boulanger; Thomas J Wang
Journal:  Eur Heart J       Date:  2014-04-16       Impact factor: 29.983

3.  Brief oral stimulation, but especially oral fat exposure, elevates serum triglycerides in humans.

Authors:  Richard D Mattes
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-12       Impact factor: 4.052

Review 4.  The role of triglycerides in cardiovascular risk.

Authors:  Puneet Gandotra; Michael Miller
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

5.  Triglycerides and cardiovascular risk.

Authors:  K E L Harchaoui; M E Visser; J J P Kastelein; E S Stroes; G M Dallinga-Thie
Journal:  Curr Cardiol Rev       Date:  2009-08

Review 6.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

Review 7.  The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.

Authors:  Henry N Ginsberg; Paul R MacCallum
Journal:  J Cardiometab Syndr       Date:  2009

Review 8.  Triglycerides and risk for coronary artery disease.

Authors:  Patrick McBride
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

9.  Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet.

Authors:  Jeff S Volek; Stephen D Phinney; Cassandra E Forsythe; Erin E Quann; Richard J Wood; Michael J Puglisi; William J Kraemer; Doug M Bibus; Maria Luz Fernandez; Richard D Feinman
Journal:  Lipids       Date:  2008-12-12       Impact factor: 1.880

10.  Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids.

Authors:  Peter P Toth; Thomas D Dayspring; Gregory S Pokrywka
Journal:  Curr Atheroscler Rep       Date:  2009-01       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.